| Both sides previous revision
Previous revision
Next revision
|
Previous revision
|
md_biochemistry [2026/06/26 13:20]
admin |
md_biochemistry [2026/06/26 13:25] (current)
admin |
| - Write note somatic hyper mutation and iso-type switching of immunoglobin. | - Write note somatic hyper mutation and iso-type switching of immunoglobin. |
| - Regulation of m-RNA stability | - Regulation of m-RNA stability |
| | - ''Type and significance of all the type of RNA. Clinical co-relation of RNA in pathogenesis of cancer , atherosclerosis and Age related Macular Degeneration (AMD)'' |
| | - ''Viral integration and transposons in human genome. Molecular impact of anti-viral drugs - Acylovir.'' |
| | - ''Regulation of eukaryotic gene expression'' |
| | - ''Journey of human genome evolution from mutation to substitution.'' |
| | - ''Tumor Supressor Gene - BRCA and p53'' |
| | - ''Meiosis vs Mitosis'' |
| | - ''Molecular defect in cystic fibrosis'' |
| | - ''Quantitative Real time PCR'' |
| | - ''DNA dependent DNA polymerase and DNA ligase.'' |
| | |
| | |
| | |
| | |
| |
| |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">List of Model Question for Paper-4 - Technique in experimental biochemistry , Recent advances</span> </html>| | |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">List of Model Question for Paper-4 - Technique in experimental biochemistry , Recent advances</span> </html>| |
| - Write performance validation protocol for these specified resource ( instrument / reagent / consumable) | - Write performance validation protocol for these specified resource ( instrument / reagent / consumable) |
| - Write a consistent quality policy and objective with defined quality indicator, for your laboratory. | - Write a consistent quality policy and objective with defined quality indicator, for your laboratory. |
| | - ''Enumerate analytical methods with it’s principle , significant and limitation of creatinine estimation and eGFR.'' |
| | - ''Definition of quality indicator with it’s standard requirements. Define quality indicator for period of sample collection to sample receipt (minimum four QI ) and sample storage (minimum four QI ) with process of it’s monitoring and measuring elements.'' |
| | - ''Principle and utility of Fourier Transform Infrared (FTIR) spectroscopy in clinical biochemistry laboratory. Approach to validate the result of FTIR.'' |
| | - ''Structure and component of “Foundation Course” for First year Indian Medical Graduate (IMG)'' |
| | - ''AETCOM'' |
| | - ''Document Control and Control of Record as per ISO 15189:2022'' |
| | - ''Use of moving average of patient data as IQC alternative'' |
| | - ''Delta Bilirubin - Define and Clinical significant.'' |
| | - ''Component and Principle of Flame Photometer'' |
| | - ''Mechanism , clinical utility and biochemical adverse event with use of GLP-1 analogues'' |
| | - ''Sample acceptance exception in case of wrong vacuette (Write minimum 4 scenario)'' |
| | |
| | |
| | |
| | |
| |
| |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">Drugs To Read With Biochemical Mechanism</span> </html>| | |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">Drugs To Read With Biochemical Mechanism</span> </html>| |